Killian Meara

While elevated BMI at baseline was not associated with increased cardiovascular risk, cumulative excess BMI was associated with an increased risk in people under 50.

Higher serum testosterone concentration was not associated with a reduced risk of developing type 2 diabetes in men older than 65.

Research presented at ENDO 2024 found that environmental stress increased the likelihood of earlier alcohol, nicotine and cannabis use in females and traumatic events increased the likelihood in males.

According to a survey, 18.9% of respondents said that the person they knew who died of a drug overdose was a family member or close friend.

The SpeedySwab COVID + FLU A&B Self-Test from Watmind is intended for at-home and point-of-care use and can simultaneously detect COVID-19, influenza A, and influenza B in 15 minutes.

Check out these important FDA updates from the month of May 2024.

The approval of Lisocabtagene maraleucel (Breyanzi; liso-cel) was based on data from the TRANSCEND-NHL-001 study, in which the therapy showed rapid and durable response rates.

Check out these featured Drug Topics expert interviews from May 2024.

Chris DesRochers, a pharmacy technician who works at a CVS in Wakefield, Rhode Island and is active in the recent organizing, discusses what motivated him and his coworkers to unionize.

Check out this list of our 10 most read stories from May 2024.

Patients with type 2 diabetes who used continuous glucose monitors combined with regular exercise had improved fasting glucose and 2 hours-postprandial glucose levels.

A recent study found that if community pharmacists were utilized to treat common conditions, it could result in significant cost-savings for the health care system.

Check out these top featured stories from Drug Topics in May 2024.

Check out important updates from the FDA for the week of May 20.

Recent research on food allergy highlights the mental health concerns of people living with a food allergy, how nutritional intervention can help children with food allergy, and that peanut introduction can reduce rates of new allergy in high-risk infants.

Savannah Roberts Clary, PharmD, BCPS, CPGx, a clinical pharmacist with Aegis Sciences Corporation, discusses what tianeptine is and how pharmacists can help warn the public about its potential hazards.

A report from Dexcom found that depression and anxiety are commonly reported in patients living with type 2 diabetes, but continuous glucose monitors can make disease management easier.

Savannah Roberts Clary, PharmD, BCPS, CPGx, a clinical pharmacist with Aegis Sciences Corporation, talks about the dangers of tianeptine and how pharmacists can help warn the public about the potential hazards of tianeptine.

Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.

Unregulated tianeptine, often referred to as “gas station heroin,” has led to serious adverse effects. But while health officials warn the public about its potential dangers, others are concerned stigmatization could ruin any future chance of the drugs medicinal use.

A poster presented at Digestive Disease Week showed that patients with MASLD taking semaglutide achieved significant weight loss while preserving skeletal muscle indices.

Check out important updates from the FDA for the week of May 13.

Amgen’s Tarlatamab-dlle (Imdelltra) is the first and only approved DLL3-targeting bispecific T-cell engager therapy for the aggressive form of lung cancer.

Efsitora (efsitora alfa) from Eli Lilly met its primary endpoint of non-inferior A1C reduction compared to insulin degludec and insulin glargine in 2 phase 3 studies.

The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.

Different weight loss therapies provide a wide range of benefits to patients with T1D—but they have some potential adverse effects.

A recent study found that, of 423 participants who were initially low responders, 90% increased their antibody concentrations to more than 400 AU/mL.

Check out important updates from the FDA for the week of May 6.

The federal agency said the delay was due to administrative constraints and did not cite any vaccine safety, efficacy or quality issues.

A single dose of Compass Pathways’ investigational COMP360 was well tolerated and showed durable improvements in CAPS-5 and SDS total scores compared to baseline.